BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 15902690)

  • 1. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
    Authier FJ; Chariot P; Gherardi RK
    Muscle Nerve; 2005 Sep; 32(3):247-60. PubMed ID: 15902690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Muscular complications of human immunodeficiency virus (HIV) infection in the era of effective anti-retroviral therapy].
    Authier FJ; Gherardi RK
    Rev Neurol (Paris); 2006 Jan; 162(1):71-81. PubMed ID: 16446625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Muscular complications in HIV infection].
    Authier FJ; Chariot P; Gherardi R
    Arch Anat Cytol Pathol; 1997; 45(2-3):174-8. PubMed ID: 9382610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Muscular involvement in HIV infection].
    Gherardi R; Chariot P; Authier FJ
    Rev Neurol (Paris); 1995 Nov; 151(11):603-7. PubMed ID: 8745623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era.
    Nguyen BY; Reveille JD
    Curr Opin Rheumatol; 2009 Jul; 21(4):404-10. PubMed ID: 19444116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatic manifestations of human immunodeficiency virus infection.
    Louthrenoo W
    Curr Opin Rheumatol; 2008 Jan; 20(1):92-9. PubMed ID: 18281864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral nerve diseases and myopathies associated with HIV infection].
    Nervenarzt; 2000 Jun; 71(6):442-50. PubMed ID: 10919138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.
    Kong HH; Myers SA
    Dermatol Ther; 2005; 18(1):58-66. PubMed ID: 15842613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
    Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J
    J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection.
    Reveille JD; Williams FM
    Best Pract Res Clin Rheumatol; 2006 Dec; 20(6):1159-79. PubMed ID: 17127202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing spectrum of the diffuse infiltrative lymphocytosis syndrome.
    Basu D; Williams FM; Ahn CW; Reveille JD
    Arthritis Rheum; 2006 Jun; 55(3):466-72. PubMed ID: 16739215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Wanke CA; Silva M; Knox TA; Forrester J; Speigelman D; Gorbach SL
    Clin Infect Dis; 2000 Sep; 31(3):803-5. PubMed ID: 11017833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle involvement in HIV-infected patients.
    Gherardi RK
    Neuropathol Appl Neurobiol; 1994 Jun; 20(3):232-7. PubMed ID: 7936072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages?
    Shikuma CM; Valcour VG; Ratto-Kim S; Williams AE; Souza S; Gerschenson M; Day L; Kim JH; Shiramizu B
    Clin Infect Dis; 2005 Jun; 40(12):1846-8. PubMed ID: 15909275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of highly active antiretroviral therapy on outcome of cholecystectomy in patients with human immunodeficiency virus infection.
    Foschi D; Cellerino P; Corsi F; Casali A; Rizzi A; Righi I; Trabucchi E
    Br J Surg; 2006 Nov; 93(11):1383-9. PubMed ID: 17022012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial studies in HAART-related lipodystrophy: from experimental hypothesis to clinical findings.
    Miró O; López S; Cardellach F; Casademont J
    Antivir Ther; 2005; 10 Suppl 2():M73-81. PubMed ID: 16152708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)].
    Arendt G
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):577-86. PubMed ID: 16217698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.